Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption

Lee, WS; Kristensen, AB; Rasmussen, TA; Tolstrup, M; Ostergaard, L; Sogaard, OS; Wines, BD; Hogarth, PM; Reynaldi, A; Davenport, MP; Emery, S; Amin, J; Cooper, DA; Kan, VL; Fox, J; Gruell, H; Parsons, MS; Kent, SJ

Kent, SJ (reprint author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kent, SJ (reprint author), Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Kent, SJ (rep

JOURNAL OF VIROLOGY, 2017; 91 (15):

Abstract

There is growing interest in utilizing antibody-dependent cellular cytotoxicity (ADCC) to eliminate infected cells following reactivation from HIV-1 l......

Full Text Link